| Product Code: ETC9464036 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sri Lanka CNV (Choroidal NeoVascularization) Market Overview |
3.1 Sri Lanka Country Macro Economic Indicators |
3.2 Sri Lanka CNV (Choroidal NeoVascularization) Market Revenues & Volume, 2021 & 2031F |
3.3 Sri Lanka CNV (Choroidal NeoVascularization) Market - Industry Life Cycle |
3.4 Sri Lanka CNV (Choroidal NeoVascularization) Market - Porter's Five Forces |
3.5 Sri Lanka CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 Sri Lanka CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Sri Lanka CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 Sri Lanka CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Sri Lanka CNV (Choroidal NeoVascularization) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of age-related macular degeneration in Sri Lanka, a major cause of choroidal neovascularization. |
4.2.2 Growing awareness and early diagnosis of eye diseases leading to higher demand for treatments such as anti-VEGF therapies. |
4.2.3 Improvements in healthcare infrastructure and access to advanced ophthalmic treatments in Sri Lanka. |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare facilities and trained ophthalmologists in Sri Lanka. |
4.3.2 High treatment costs associated with advanced treatments for choroidal neovascularization. |
4.3.3 Challenges in reimbursement policies and insurance coverage for expensive treatment options. |
5 Sri Lanka CNV (Choroidal NeoVascularization) Market Trends |
6 Sri Lanka CNV (Choroidal NeoVascularization) Market, By Types |
6.1 Sri Lanka CNV (Choroidal NeoVascularization) Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 Sri Lanka CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 Sri Lanka CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Fluorescein AngiographyOptical Coherence Tomography, 2021- 2031F |
6.1.4 Sri Lanka CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Sri Lanka CNV (Choroidal NeoVascularization) Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Sri Lanka CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Anti-VEGF, 2021- 2031F |
6.2.3 Sri Lanka CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Photodynamic Therapy, 2021- 2031F |
6.2.4 Sri Lanka CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Thermal Laser, 2021- 2031F |
6.2.5 Sri Lanka CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Sri Lanka CNV (Choroidal NeoVascularization) Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 Sri Lanka CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Sri Lanka CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 Sri Lanka CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.5 Sri Lanka CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Sri Lanka CNV (Choroidal NeoVascularization) Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Sri Lanka CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Sri Lanka CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.4 Sri Lanka CNV (Choroidal NeoVascularization) Market Revenues & Volume, By online Pharmacies, 2021- 2031F |
6.4.5 Sri Lanka CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
7 Sri Lanka CNV (Choroidal NeoVascularization) Market Import-Export Trade Statistics |
7.1 Sri Lanka CNV (Choroidal NeoVascularization) Market Export to Major Countries |
7.2 Sri Lanka CNV (Choroidal NeoVascularization) Market Imports from Major Countries |
8 Sri Lanka CNV (Choroidal NeoVascularization) Market Key Performance Indicators |
8.1 Number of patients diagnosed with choroidal neovascularization annually. |
8.2 Adoption rate of advanced treatment modalities for CNV in Sri Lanka. |
8.3 Average waiting time for patients to receive treatment for CNV in healthcare facilities. |
8.4 Patient satisfaction scores with the quality of care and treatment outcomes for CNV in Sri Lanka. |
8.5 Rate of complications or adverse events associated with CNV treatments in Sri Lanka. |
9 Sri Lanka CNV (Choroidal NeoVascularization) Market - Opportunity Assessment |
9.1 Sri Lanka CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 Sri Lanka CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Sri Lanka CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 Sri Lanka CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Sri Lanka CNV (Choroidal NeoVascularization) Market - Competitive Landscape |
10.1 Sri Lanka CNV (Choroidal NeoVascularization) Market Revenue Share, By Companies, 2024 |
10.2 Sri Lanka CNV (Choroidal NeoVascularization) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here